ArchiMed picks up Deallus
Healthcare-focused private equity firm ArchiMed has secured majority control of London-based Deallus Consulting.
The all-equity deal saw Deallus's senior management also investing.
This acquisition marks ArchiMed's fourth since closing its debut fund on its €150m hard-cap in June 2015. Previous deals include the €12m purchase of Medistream, a minority stake in Primo and the acquisition of RehabWorks.
Company
Deallus is a life-sciences-focused consultant, providing advice on product introduction and processes for maintaining corporate innovation. It works with pharmaceutical, biotech and vaccine businesses.
Deallus was founded in 2004 and is headquartered in London with further offices in New York, Los Angeles, Princeton, Tokyo and Singapore. The company employs 80 consultants and generates turnover of £15m.
People
Robin Filmer-Wilson is a managing partner at ArchiMed. Claudio D'Ambrosio is CEO of Deallus.
More on UK / Ireland
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater